On June 30, 2023, the Centers for Medicare and Medicaid Services (CMS) released its much-anticipated final guidance ("Final Guidance") for the Medicare Drug Price Negotiation Program.
On June 30, 2023, the Centers for Medicare & Medicaid Services ("CMS") issued its final guidance memorandum1 (the "Final Guidance") on the implementation of the Inflation Reduction Act ("IRA") Medicare Drug Price Negotiation Program for the Initial Price Applicability Year of 2026.
On March 15, 2023, the Centers for Medicare & Medicaid Services (CMS) issued an initial guidance regarding the Medicare Drug Price Negotiation Program (Negotiation Program) established.
IRA Provision: The Medicare Drug Price Negotiation Program - The Centers for Medicare & Medicaid Services (CMS) issued a fact sheet and initial guidance for the.
On August 16, 2022, President Biden signed H.R. 5376 – Inflation Reduction Act of 2022. This new law establishes the ability for the Secretary of Health and Human Services to establish a Drug Price Negotiation Program that .